Heart Test Laboratories
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 15
- Market Cap
- -
- Introduction
Heart Test Laboratories, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.
Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population
- Conditions
- Health Screening
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Heart Test Laboratories, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT05364541
- Locations
- 🇺🇸
University of Texas Medical Center, Dallas, Texas, United States
MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram
- Conditions
- Cardiac Disease
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Heart Test Laboratories, Inc.
- Target Recruit Count
- 575
- Registration Number
- NCT04804969
- Locations
- 🇺🇸
Scripps Memorial Hospital, La Jolla, California, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Montefiore Medical Center, Bronx, New York, United States